Bioinformatics-Driven Structural and Pharmacological Analysis of SLITRK1 in Tourette Syndrome: Impact of S656M Mutation Using Molecular Dynamics, Docking, and Reinforcement Learning
Authors:
- Emre AktaşEAEmre Aktaş
- Alirıza İslimAİAlirıza İslim
- Kevser Kübra KırboğaKKKevser Kübra Kırboğa
- Derya YıldızDYDerya Yıldız
- Nehir Özdemir ÖzgentürkNÖNehir Özdemir Özgentürk
- Mithun RudrapalMithun Rudrapal
- Johra KhanJKJohra Khan
- Raghu Ram AcharRARaghu Ram Achar
- Ekaterina SilinaESEkaterina Silina
- Natalia ManturovaNMNatalia Manturova
- Victor StupinVSVictor Stupin
Open Access
- 27 January 2025
- journal article
- research article
- Published by MDPI AG in Computation
- Vol. 13 (2) , 29
Abstract
SLITRK1 is a critical protein involved in neural development and is associated with various neurological disorders, including Tourette Syndrome. This study investigates the structural dynamics, intrinsic disorder propensity, and pharmacological interactions of SLITRK1, with a particular focus on amino acid substitutions and their pathological implications. A comprehensive computational framework was employed, including intrinsic disorder region analysis, transmembrane topology predictions, and stability assessments of SLITRK1 variants. Integrated with reinforcement learning (RL), molecular docking and dynamics simulations were used to evaluate the pharmacotherapeutic potential of drugs commonly prescribed for Tourette Syndrome, such as Pimozide, Aripiprazole, Risperidone, and Haloperidol. Structural analyses revealed that the S656M mutation significantly alters SLITRK1’s 3D conformation, biological functions, and drug binding profiles. Among the tested drugs, Aripiprazole exhibited the highest binding affinity across various SLITRK1 variants, with reinforcement learning highlighting a notable interaction with the S659K mutation. These findings were supported by Ramachandran plot and molecular dynamics analyses, which identified mutation-induced structural and dynamic changes. This study provides an integrative analysis of SLITRK1, offering insights into its role in Tourette Syndrome and laying a foundation for targeted therapeutic strategies to mitigate SLITRK1-related neurological disorders.Keywords
This publication has 80 references indexed in Scilit:
- Using evolutionary data to make sense of macromolecules with a “face‐lifted” ConSurfProtein Science, 2023
- Machine Intelligence and Data Science Applications2023
- Paternal factors in recurrent pregnancy loss: an insight through analysis of non-synonymous single-nucleotide polymorphism in human testis-specific chaperone HSPA2 geneEnvironmental Science and Pollution Research, 2021
- PANTHER: Making genome‐scale phylogenetics accessible to allProtein Science, 2021
- Non-invasive brain stimulation as therapy: systematic review and recommendations with a focus on the treatment of Tourette syndromeExperimental Brain Research, 2021
- The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactionsProtein Science, 2020
- On the Need to Develop Guidelines for Characterizing and Reporting Intrinsic Disorder in ProteinsProteomics, 2019
- Association of IMMP2L deletions with autism spectrum disorder: A trio family study and meta‐analysisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2017
- Comprehensive review of methods for prediction of intrinsic disorder and its molecular functionsCellular and Molecular Life Sciences, 2017
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004